Recent studies have strongly suggested that circulating CD26 LSCs in peripheral blood (PB) are specific for CML and flow cytometric evaluation of CD26 expression on LSCs can be used as a new, powerful tool for diagnosis of CML as well as for follow-up [9-13]. The gene discussed is DPP4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.